The US investment bank achieved record net revenues of US$15.7 billion in the first quarter of 2021, compared with US$9.8 billion during the same period in 2020.
Morgan Stanley saw its structured product sales skyrocket by US$1 billion compared to the prior year period during the first quarter of 2021 to reach US$3.7 billion. SRP data shows that Morgan Stanley topped the US league tables as the most dominant issuer group with 828 structured products (US$3.76 billion), compared with 746 products (US$2.46 billion) in Q1 20. Closely tailing behind are Barclays with 662 products worth US$3.5 billion, Goldman Sachs with 899 products valued at US$3.4 billion
Continue reading with a subscription to the SRP market intelligence platform.
Request DemoAlready a subscriber? Login